RGEN

Repligen Corp

Price:

141.93

USD

Volume:

489,903.00

United States | Life Sciences Tools & Services

-100.59 %

Upside

As of 2024-09-13, the Fair Value of Repligen Corp (RGEN) is -0.84 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 141.93 USD, the upside of Repligen Corp is -100.59%.

Note: valuation result may not be accurate due to the company's negative EPS.

141.93 USD

Stock Price

-0.84 USD

Fair Price

Peter Lynch's formula is:

RGEN Fair Value

= Earnings Growth Rate x TTM EPS
RGEN Fair Value

= 25.00 x -0.03
RGEN Fair Value

= -0.84
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | 21.40 | 59.90 | 128.30 | 186.00 | 41.58 | 87.44 |

YoY growth | 28.92% | 179.91% | 114.19% | 44.97% | -77.65% | 58.07% |

Market Cap (mil) | 7,949.50 |

P/E | |

Forward P/E | 132.33x |

EPS | -0.03 |

Avg earnings growth rate | 58.07% |

TTM earnings | -1.87 |